CytomX/$CTMX
About CytomX
Ticker
Industry
Employees
CytomX Metrics
$66M
5.21
$0.16
1.06
-
Price and volume
Market cap
$66M
Beta
1.06
52-week high
$5.85
52-week low
$0.81
Average daily volume
1.6M
Financial strength
Current ratio
1.042
Quick ratio
1.014
Long term debt to equity
-23.862
Total debt to equity
-45.186
Management effectiveness
Return on assets (TTM)
2.33%
Return on equity (TTM)
-37.03%
Valuation
Price to earnings (TTM)
5.207
Price to revenue (TTM)
0.554
Price to book
-2.81
Price to tangible book (TTM)
-2.63
Price to free cash flow (TTM)
-0.79
Growth
Revenue change (TTM)
33.66%
Earnings per share change (TTM)
-210.88%
3-year revenue growth (CAGR)
24.12%
3-year earnings per share growth (CAGR)
-48.92%
What the Analysts think about CytomX
Analyst Ratings
CytomX Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
CytomX Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
CytomX News
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
CytomX Therapeutics, Inc. (CTMX) Q3 2024 Earnings Call Transcript
FAQs
What’s the current market cap for CytomX stock?
What is the P/E ratio for CytomX stock?
Does CytomX stock pay dividends?
No, CytomX (CTMX) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next CytomX dividend payment date?
CytomX (CTMX) stock does not pay dividends to its shareholders.
What is the beta indicator for CytomX?
CytomX (CTMX) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.